AIA Group Ltd cut its holdings in Biogen Inc. (NASDAQ:BIIB – Free Report) by 8.3% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 1,563 shares of the biotechnology company’s stock after selling 141 shares during the period. AIA Group Ltd’s holdings […]
Biogen Inc. (NASDAQ:BIIB – Free Report) – Investment analysts at Wedbush dropped their Q1 2024 earnings per share estimates for Biogen in a report issued on Wednesday, April 17th. Wedbush analyst L. Chico now anticipates that the biotechnology company will post earnings of $3.25 per share for the quarter, down from their prior estimate of […]
Tobam reduced its position in shares of Biogen Inc. (NASDAQ:BIIB – Free Report) by 7.3% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 11,922 shares of the biotechnology company’s stock after selling 933 shares during the quarter. Tobam’s holdings in Biogen were worth […]
Tritonpoint Wealth LLC bought a new position in shares of Biogen Inc. (NASDAQ:BIIB – Free Report) during the fourth quarter, Holdings Channel reports. The fund bought 2,023 shares of the biotechnology company’s stock, valued at approximately $523,000. Other institutional investors have also recently added to or reduced their stakes in the company. Norges Bank bought […]
Biogen (NASDAQ:BIIB – Get Free Report) and BioAtla (NASDAQ:BCAB – Get Free Report) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, institutional ownership, valuation, dividends, analyst recommendations, earnings and profitability. Institutional and Insider Ownership 87.9% of Biogen shares are held […]